FibroGen【FGEN】株式ニュース

名称	銘柄コード	市場	種別
FibroGen Inc	FGEN	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.07	6.80%	1.10	07:04:23

始値	安値	高値	終値	前日終値
1.04	1.01	1.13	1.10	1.03

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/18	21:00	GLOBE	FibroGen to Host Part II of Virtual KOL Investor Event..
2024/6/14	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/11	07:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	08:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	08:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	05:12	EDGAR2	Form 8-K - Current report
2024/6/07	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/07	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/07	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/07	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/07	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/07	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/04	05:05	GLOBE	FibroGen Announces Clinical Trial Supply Agreement with..
2024/6/04	05:02	GLOBE	FibroGen Announces FDA Clearance of Investigational New Drug..
2024/6/03	20:00	GLOBE	FibroGen to Present at Goldman Sachs 45th Annual Global..
2024/5/24	06:05	GLOBE	FibroGen Announces Presentation of Positive Interim Data..
2024/5/08	00:55	APS	Traders Rush To Buy Biotech Following Q1 Earnings Beat
2024/5/07	20:00	GLOBE	FibroGen to Participate in Upcoming Investor Conferences
2024/5/07	05:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/07	05:05	EDGAR2	Form 8-K - Current report
2024/5/07	05:02	GLOBE	FibroGen Reports First Quarter 2024 Financial Results
2024/4/29	20:00	GLOBE	FibroGen to Report First Quarter 2024 Financial Results
2024/4/25	05:02	GLOBE	FibroGen Announces Clinical Data from Dose Escalation Phase..
2024/4/03	06:46	GLOBE	FibroGen Announces Topline Results from Phase 1 Monotherapy..
2024/3/26	20:00	GLOBE	FibroGen to Present at 23rd Annual Needham Virtual..
2024/3/11	20:00	GLOBE	FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
2024/3/09	09:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/09	09:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/09	09:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/27	06:08	EDGAR2	Form 8-K - Current report
2024/2/27	06:06	GLOBE	FibroGen Reports Fourth Quarter and Full Year 2023 Financial..
2024/2/27	06:05	GLOBE	FibroGen Regains All Rights to Roxadustat from AstraZeneca..
2024/2/24	10:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/24	10:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/24	10:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/20	21:00	GLOBE	FibroGen to Report Fourth Quarter and Full Year 2023..
2024/2/15	05:37	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/06	10:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/05	21:00	GLOBE	FibroGen To Host Part I of Virtual KOL Investor Event Series..
2024/1/25	21:00	GLOBE	FibroGen Announces Completion of the Pamrevlumab Arm in..
2023/12/27	09:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/12	06:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/12	06:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/12	06:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/10	07:02	GLOBE	FibroGen Presents Data from Phase 3 MATTERHORN Trial of..
2023/11/07	06:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07	06:05	EDGAR2	Form 8-K - Current report
2023/11/07	06:01	GLOBE	FibroGen Reports Third Quarter 2023 Financial Results
2023/11/04	05:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/28	05:30	EDGAR2	Form 8-K - Current report